BSX logo Boston Scientific Corporation +
Boston Scientific Corporation
+

Boston Scientific Corporation (BSX) Business News

Track Boston Scientific Corporation in real time with a live news feed covering Boston Scientific Corporation stock news, official press releases, company announcements, and an archive of historical Boston Scientific Corporation news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Boston Scientific (NYSE:BSX) and Sysmex (OTCMKTS:SSMXY) Critical Survey

Defense World

1:29 AM | Monday | Oct 12, 2026

news photo
Loading...

Sysmex (OTCMKTS:SSMXY - Get Free Report) and Boston Scientific (NYSE: BSX - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, dividends and profitability. Valuation and Earnings This table compares Sysmex and Boston

Read full article redirect
1:29 AM | Monday | Oct 12, 2026

Boston Scientific (NYSE:BSX) and Sysmex (OTCMKTS:SSMXY) Critical Survey

Defense World

Sysmex (OTCMKTS:SSMXY - Get Free Report) and Boston Scientific (NYSE: BSX - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, dividends and profitability. Valuation and Earnings This table compares Sysmex and Boston

Read full article arrow
News Thumbnail
1:29 AM | Monday | Oct 12, 2026

Boston Scientific (NYSE:BSX) and Sysmex (OTCMKTS:SSMXY) Critical Survey

Defense World

Sysmex (OTCMKTS:SSMXY - Get Free Report) and Boston Scientific (NYSE: BSX - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, dividends and profitability. Valuation and Earnings This table compares Sysmex and Boston

Read full article arrow
News Thumbnail
7:01 PM | Friday | Oct 9, 2026

Why Boston Scientific (BSX) Outpaced the Stock Market Today

Zacks Investment Research

Boston Scientific (BSX) reached $42.73 at the closing of the latest trading day, reflecting a +1.64% change compared to its last close.

Read full article arrow
News Thumbnail
10:01 AM | Thursday | Oct 8, 2026

Boston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research

Recently, Zacks.com users have been paying close attention to Boston Scientific (BSX). This makes it worthwhile to examine what the stock has in store.

Read full article arrow
News Thumbnail
4:32 AM | Thursday | Oct 8, 2026

Boston Scientific (NYSE:BSX) Reaches New 1-Year Low – Time to Sell?

Defense World

Boston Scientific Corporation (NYSE: BSX - Get Free Report) shares hit a new 52-week low on Thursday. The company traded as low as $41.50 and last traded at $41.5470, with a volume of 15871082 shares changing hands. The stock had previously closed at $42.
19. Wall Street Analysts Forecast Growth BSX has been the subject of a

Read full article arrow
News Thumbnail
6:00 AM | Wednesday | Oct 7, 2026

Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer

PRNewsWire

New operating structure designed to increase efficiency and support continued growth MARLBOROUGH, Mass., Oct. 7, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the appointment of Joseph M.

Read full article arrow
News Thumbnail
7:01 PM | Friday | Oct 2, 2026

Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know

Zacks Investment Research

In the latest trading session, Boston Scientific (BSX) closed at $42.6, marking a -1.46% move from the previous day.

Read full article arrow
News Thumbnail
4:45 PM | Thursday | Oct 1, 2026

Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029

GlobeNewsWire

Boston Scientific released the full $8 million holdback on schedule and with no claims Escrow release is the third funding catalyst Elutia has delivered in 2026, following the August closings of its Avenue Capital loan facility and SimpliDerm® divestiture The Company is now fully funded through the first year of the expected NXT-41x launch and into 2029 GAITHERSBURG, Md., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced it has received the full $8 million held in escrow in connection with the sale of its BioEnvelope business to Boston Scientific Corporation (NYSE: BSX).

Read full article arrow
News Thumbnail
11:46 AM | Wednesday | Sep 30, 2026

Boston Scientific's MedSurg Diversification Bolsters Growth Prospects

Zacks Investment Research

BSX's MedSurg segment supports growth, with Endoscopy and Neuromodulation gains offsetting Urology challenges and portfolio gaps.

Read full article arrow
News Thumbnail
2:29 AM | Wednesday | Sep 30, 2026

Boston Scientific Corporation (NYSE:BSX) Stock Has Average Price Target of $70.19

Defense World

Shares of Boston Scientific Corporation (NYSE: BSX - Get Free Report) have been assigned an average rating of "Moderate Buy" from the thirty-one research firms that are covering the company, MarketBeat reports. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and twenty-three have issued a buy rating on

Read full article arrow
News Thumbnail
5:03 AM | Tuesday | Sep 29, 2026

Rep. Kevin Hern Sells Shares of Boston Scientific Corporation (NYSE:BSX)

Defense World

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Boston Scientific Corporation (NYSE: BSX). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in Boston Scientific stock on August 31st. The trade occurred in the Representative's "HERN FAMILY FOUNDATION" account. Representative Kevin Hern also recently made the following

Read full article arrow
News Thumbnail